The Mar4Health project was developed to explore the therapeutic potential of molecules previously optimized by Sea4Us, identifying the most suitable profiles for diseases lacking adequate treatment, with a strong component of abnormal neuronal activity and in which ion channels are potential therapeutic targets.

We started with ten initially selected molecules and, through activity, efficacy, and toxicity testing, selected the most promising candidates. Of these, three were chosen, and proof of concept was established in disease models: chemotherapy-induced neuropathic pain, osteoarthritis pain, and epilepsy.

Through this project, we were able to advance three new therapeutic programs. And who better to tell this story than Marília Silva and Eduardo Moura, who led the project?

The Mar4Health project no. 14315 is supported by the Lisbon Regional Programme, Portugal 2030, and the European Union.

European Funds Closer to You.